Logo image of MBOT

MICROBOT MEDICAL INC (MBOT) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MBOT - US59503A2042 - Common Stock

2.49 USD
+0.28 (+12.67%)
Last: 12/3/2025, 8:00:01 PM
2.53 USD
+0.04 (+1.61%)
After Hours: 12/3/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MBOT. MBOT was compared to 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for MBOT as it has an excellent financial health rating, but there are worries on the profitability. MBOT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MBOT had negative earnings in the past year.
In the past year MBOT has reported a negative cash flow from operations.
In the past 5 years MBOT always reported negative net income.
In the past 5 years MBOT always reported negative operating cash flow.
MBOT Yearly Net Income VS EBIT VS OCF VS FCFMBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MBOT has a worse Return On Assets (-38.36%) than 61.70% of its industry peers.
MBOT's Return On Equity of -41.86% is in line compared to the rest of the industry. MBOT outperforms 53.72% of its industry peers.
Industry RankSector Rank
ROA -38.36%
ROE -41.86%
ROIC N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
MBOT Yearly ROA, ROE, ROICMBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

MBOT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MBOT Yearly Profit, Operating, Gross MarginsMBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

8

2. Health

2.1 Basic Checks

MBOT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MBOT has been increased compared to 5 years ago.
There is no outstanding debt for MBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBOT Yearly Shares OutstandingMBOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MBOT Yearly Total Debt VS Total AssetsMBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 27.75 indicates that MBOT is not in any danger for bankruptcy at the moment.
MBOT has a better Altman-Z score (27.75) than 98.40% of its industry peers.
MBOT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 27.75
ROIC/WACCN/A
WACCN/A
MBOT Yearly LT Debt VS Equity VS FCFMBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

A Current Ratio of 12.06 indicates that MBOT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 12.06, MBOT belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.
A Quick Ratio of 12.06 indicates that MBOT has no problem at all paying its short term obligations.
MBOT has a better Quick ratio (12.06) than 96.81% of its industry peers.
Industry RankSector Rank
Current Ratio 12.06
Quick Ratio 12.06
MBOT Yearly Current Assets VS Current LiabilitesMBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

1

3. Growth

3.1 Past

MBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.21%, which is quite impressive.
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 46.21% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y66.92%
EPS Next 2Y46.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MBOT Yearly Revenue VS EstimatesMBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2025 2026 20M 40M 60M
MBOT Yearly EPS VS EstimatesMBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -200 -400 -600 -800

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

MBOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 24.41, which indicates a rather expensive current valuation of MBOT.
Based on the Price/Forward Earnings ratio, MBOT is valued a bit cheaper than 77.66% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.20. MBOT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 24.41
MBOT Price Earnings VS Forward Price EarningsMBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MBOT Per share dataMBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

MBOT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MBOT's earnings are expected to grow with 46.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.21%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MBOT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MICROBOT MEDICAL INC

NASDAQ:MBOT (12/3/2025, 8:00:01 PM)

After market: 2.53 +0.04 (+1.61%)

2.49

+0.28 (+12.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-23 2026-03-23/amc
Inst Owners8.88%
Inst Owner Change136.44%
Ins Owners1.47%
Ins Owner Change0%
Market Cap167.23M
Revenue(TTM)N/A
Net Income(TTM)-12.71M
Analysts82.86
Price Target12.24 (391.57%)
Short Float %6.9%
Short Ratio1.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.79%
Min EPS beat(2)-22.55%
Max EPS beat(2)32.13%
EPS beat(4)1
Avg EPS beat(4)-3.67%
Min EPS beat(4)-22.55%
Max EPS beat(4)32.13%
EPS beat(8)5
Avg EPS beat(8)5.03%
EPS beat(12)9
Avg EPS beat(12)8.58%
EPS beat(16)10
Avg EPS beat(16)3.13%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)25%
EPS NY rev (1m)0%
EPS NY rev (3m)29.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37%
Revenue NY rev (1m)0%
Revenue NY rev (3m)245.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.41
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.51
P/tB 5.51
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)0.1
Fwd EY4.1%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.36%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-152.25%
ROA(5y)-111.82%
ROE(3y)-247.81%
ROE(5y)-171.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 38.16%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.06
Quick Ratio 12.06
Altman-Z 27.75
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)46.2%
Cap/Depr(5y)70.94%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65%
EPS Next Y66.92%
EPS Next 2Y46.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.56%
OCF growth 3YN/A
OCF growth 5YN/A

MICROBOT MEDICAL INC / MBOT FAQ

What is the ChartMill fundamental rating of MICROBOT MEDICAL INC (MBOT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MBOT.


What is the valuation status of MICROBOT MEDICAL INC (MBOT) stock?

ChartMill assigns a valuation rating of 3 / 10 to MICROBOT MEDICAL INC (MBOT). This can be considered as Overvalued.


How profitable is MICROBOT MEDICAL INC (MBOT) stock?

MICROBOT MEDICAL INC (MBOT) has a profitability rating of 0 / 10.


What is the expected EPS growth for MICROBOT MEDICAL INC (MBOT) stock?

The Earnings per Share (EPS) of MICROBOT MEDICAL INC (MBOT) is expected to grow by 66.92% in the next year.